Assignee

Mederi Therapeutics, Inc.

Patents = 54

Forward Citations = 2,664

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

26 inventors (with patents filed for the assignee):

Mederi Therapeutics, Inc. is a medical device company dedicated to the development and commercialization of innovative therapies for gastrointestinal diseases. Their flagship product, the Stretta System, offers a non-surgical solution for the treatment of gastroesophageal reflux disease (GERD). With a focus on improving patient outcomes and quality of life, Mederi Therapeutics aims to provide effective and minimally invasive treatments for a range of gastrointestinal conditions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com